Rothblatt Martine A

Chairperson &CEO | Director

2 companies

Insider Signal Score

Good

Trades Analyzed

304

12M Win Rate

53.6%

Avg 3M Return

-6.6%

Avg 12M Return

-1.6%

Rothblatt Martine A is a Chairperson &CEO at UNITED THERAPEUTICS Corp with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 104 sells.

Estimated insider holdings value: $176.3M based on current market prices.

Holdings by Company

UTHRJul 30, 2026

Current Shares333.9K

Value$176.09M

Net Activity-397,910

Bought: 0Sold: 397.9K

BETAJun 11, 2026

Current Shares8.2K

Value$183.1K

Net Activity0

Bought: 0Sold: 0

Transaction History

Showing 10 filings (page 9)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 6, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	6,723	$260.15	$1,748,958.13	-27.3%	+25.0%	+13.2%
May 2, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$254.15	$1,829,903.18	-16.3%	+21.4%	+14.1%
Apr 30, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$237.00	$1,706,365.61	-32.7%	+43.1%	+29.3%
Apr 26, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$235.36	$1,694,624.89	-54.0%	+43.8%	+24.6%
Apr 24, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	6,911	$237.47	$1,641,170.21	-24.4%	+42.1%	+25.1%
Apr 22, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$236.69	$1,704,173.99	-40.2%	+42.1%	+25.1%
Apr 18, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$236.80	$1,704,990.23	-29.0%	+39.9%	+20.2%
Apr 16, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$233.72	$1,682,818.90	-37.3%	+41.2%	+23.0%
Apr 12, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$237.19	$1,707,775.42	-35.0%	+39.2%	+20.9%
Apr 10, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	28,800	$237.21	$6,831,736.68	-29.1%	+35.7%	+17.3%

← PrevPage 9Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC